Updates on the European Approval to Launch the Freestyle Libre System, FDA “Tentative Approval” of BI/Lilly’s insulin glargine Basaglar and NIH $20 Million commitment for Pivotal Artificial Pancreas Studies.
Diatribe – New, Now and Next. September 2014 Edition
Posted in Glucose & Insulin Other News